|
|
$175.00
|
Pharma Clinical Trial Services: World Market 2013-2023
1/1/2013 | published by: Visiongain
... It explains trends, opportunities and commercial prospects. Our study lets you assess sales data at overall world market, submarket and national level. There you find the most promising and lucrative areas in clinical trial outsourcing, ...
|
read more...
|
$2,497.00
|
Global Markets and Technologies for Biofuel Enzymes
1/1/2013 | published by: BCC Research
... from 2010 and 2011, estimates for 2012, and projections of compound annual growth rates (CAGRs) through 2017 Identification of markets by industrial end users, such as the aviation industry, road transport, heating purposes, and off-road ...
|
read more...
|
$5,450.00
|
|
|
$5,450.00
|
Genmab A/S - SWOT, Strategy and Corporate Finance Report
1/1/2013 | published by: MarketLine
... actions, providing a 360° view of the company. Features: Detailed information on Genmab A/S required for business and competitor intelligence needs A study of the major internal and external factors affecting Genmab A/S in the ...
|
read more...
|
$175.00
|
|
|
$175.00
|
Pharmaceutical Industry in the United States
1/1/2013 | published by: Aruvian's R'search
... and vaccines that prevent and treat over 150 conditions were approved by the FDA.3 The FDA also gave the go-ahead for numerous new indications for previously approved medicines, allowing physicians to tailor treatment strategies to ...
|
read more...
|
$450.00
|
|
|
$175.00
|
|
|
$4,400.00
|
|
|
$325.00
|
Biologic Imaging Reagents: Technologies and Global Markets
1/1/2013 | published by: BCC Research
... of global market trends, with data from 2011, estimates for 2012, and projections of compound annual growth rates (CAGRs) through 2017 Coverage of fluorescent probes and dyes; imaging nanomaterials (including quantum dots and other nanoparticles); ...
|
read more...
|
$5,450.00
|
|
|
$175.00
|
Portable Analysis Instrumentation
1/1/2013 | published by: BCC Research
... data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018 Discussion of the industry on a worldwide basis, from a product perspective as well as a technology perspective Examination ...
|
read more...
|
$5,450.00
|
|
|
$3,975.00
|
|
|
$175.00
|
|
|
$175.00
|
Point-of-Delivery Drug Reconstitution Systems to 2017
1/1/2013 | published by: Greystone Research Associates
... temperatures and to preserve their shelf life must be either stored at low temperature (the so-call 'cold chain') or processed into a form that will preserve their pharmacological efficacy until they reach their therapeutic destination. ...
|
read more...
|
$3,850.00
|
Closed Drug Transfer Systems
1/1/2013 | published by: Greystone Research Associates
... area that is at the forefront of attempts to mitigate exposure to cytotoxic drugs is clinical oncology, a field that – in spite of promising new drugs based on therapeutic antibodies – continues to rely ...
|
read more...
|
$2,850.00
|
|
|
$325.00
|
|
|
$325.00
|
|
|
$325.00
|
Novartis AG - SWOT, Strategy and Corporate Finance Report
1/1/2013 | published by: MarketLine
... actions, providing a 360° view of the company. Features: Detailed information on Novartis AG required for business and competitor intelligence needs A study of the major internal and external factors affecting Novartis AG in the ...
|
read more...
|
$175.00
|
|
|
$175.00
|
|
|
$325.00
|
|
|
$595.00
|